IGF2BP1 and hepatocellular carcinoma: PTPN13/IGF2BP1/c-Myc signaling pathway subsequently can enhance glutamine metabolism, resulting in increased glutathione levels and the glutathione/glutathione disulfide ratio in HCC cells.103